Address
:
[go:
up one dir
,
main page
]
Include Form
Remove Scripts
Accept Cookies
Show Images
Show Referer
Rotate13
Base64
Strip Meta
Strip Title
Session Cookies
Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37015151)
Watch
English
HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.
scientific article published on 30 June 2008
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
2602947
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591932%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 January 2020
title
HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
2602947
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591932%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 January 2020
author
Amanda K Paulson
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
2602947
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591932%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 January 2020
Flora Iovino
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
2602947
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591932%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 January 2020
author name string
H Korkaya
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
2602947
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591932%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 January 2020
M S Wicha
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
2602947
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591932%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 January 2020
language of work or name
English
0 references
publication date
30 June 2008
1 reference
stated in
Europe PubMed Central
PMC publication ID
2602947
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591932%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 January 2020
published in
Oncogene
1 reference
stated in
Europe PubMed Central
PMC publication ID
2602947
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591932%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 January 2020
volume
27
1 reference
stated in
Europe PubMed Central
PMC publication ID
2602947
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591932%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 January 2020
issue
47
1 reference
stated in
Europe PubMed Central
PMC publication ID
2602947
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591932%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 January 2020
page(s)
6120-6130
1 reference
stated in
Europe PubMed Central
PMC publication ID
2602947
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591932%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 January 2020
cites work
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Selective targeting of cancer stem cells: a new concept in cancer therapeutics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Phosphoinositide 3-kinases and regulation of embryonic stem cell fate
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Cancer stem cells: an old idea--a paradigm shift
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
The role of ErbB inhibitors in trastuzumab resistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Prospective identification of tumorigenic breast cancer cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Immunohistochemical studies of early breast cancer evolution
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
29 September 2017
Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
27 June 2018
Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
27 June 2018
HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
4 September 2018
HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
4 September 2018
Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
4 September 2018
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2602947
retrieved
4 September 2018
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FONC.2008.207
retrieved
31 March 2020
[Herceptin, a monoclonal humanized antibody anti-HER2: a major therapeutic progress in breast cancers overexpressing this oncogene?]
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18591932
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1038/ONC.2008.207
1 reference
stated in
Europe PubMed Central
PMC publication ID
2602947
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591932%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 January 2020
PMC publication ID
2602947
1 reference
stated in
Europe PubMed Central
PMC publication ID
2602947
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591932%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 January 2020
PubMed publication ID
18591932
1 reference
stated in
Europe PubMed Central
PMC publication ID
2602947
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591932%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 January 2020
ResearchGate publication ID
5261495
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit